Abstract
Normal human somatic cells undergo limited cell division cycles and enter irreversible replication arrest called senescence. Cellular senescence of many human cell types is regulated by the length and status of telomeric sequences, which is shortened after each round of DNA replication. Telomeres can be rejuvenated by telomerase, an enzyme which carries out de novo synthesis of telomeric DNA. Telomerase is a ribonucleoprotein complex composed minimally of telomere reverse transcriptase gene (hTERT) and RNA template (hTR), and its enzyme activity in cells is primarily limited by the level of hTERT expression. Therefore, telomerase activity in cells can be reconstituted by overexpression of hTERT, frequently resulting in extension of replicative life span or immortalization. It is well established that the effect of telomerase reconstitution on cellular life span is clearly cell typedependent because telomere shortening is not the only limiting factor of cellular life span. However, telomerase activity appears to be a requirement for cellular immortalization, irrespective of the cell types. In this article, we discuss the detailed methods to extend the in vitro replicative life span of primary human cells by ectopic expression of hTERT.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614–636.
Itahana, K., Campisi, J., and Dimri, G. P. (2004) Mechnisms of cellular senescence in human and mouse cells. Biogerontology 5, 1–10.
Campisi, J. (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513–522.
Karlseder, J., Smogorzewska, A., and de Lange, T. (2002) Senescence induced by altered telomere state, not telomere loss. Science 295, 2446–2449.
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. (1999) p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321–1325.
Harley, C. B., Futcher, B., Greider, C. W. (1990) Telomeres shorten during aging of human fibroblasts. Nature 345, 458–460.
Greider, C. W. and Blackburn, E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405–413.
Meyerson, M., Counter, C. M., Eaton, E. N., et al. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785–795.
Counter, C. M., Meyerson, M., Eaton, E. N., et al. (1998) Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16, 1217–1222.
MacKenzie, K. L., Franco, S., May, C., Sadelain, M., and Moore, M. A. (2000) Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp. Cell Res. 259, 336–350.
Di Donna, S., Mamchaoui, K., Cooper, R. N., et al. (2003) Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol. Cancer Res. 1, 643–653.
Darimont, C. and Mace, K. (2003) Immortalization of human preadipocytes. Biochimie 85, 1231–1233.
Migliaccio, M., Amacker, M., Just, T., et al. (2000) Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization. J. Immunol. 165, 4978–4984.
Dickson, M. A., Hahn, W. C., Ino, Y., et al. (2000) Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20, 1436–1447.
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., Klingelhutz, A. J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88.
Noble, J. R., Zhong, Z. H., Neumann, A. A., Melki, J. R., Clark, S. J., and Reddel, R. R. (2004) Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts. Oncogene 23, 3116–3121.
Milyavsky, M., Shats, I., Erez, N., et al. (2003) Prolonged culture of telomeraseimmortalized human fibroblasts leads to a premalignant phenotype. Cancer Res. 63, 7147–7157.
Shin, K. H., Kang, M. K., Dicterow, E., Kameta, A., Baluda, M. A., and Park, N.-H. (2004) Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin. Cancer Res. 10, 2551–2560.
Kang, M. K., Bibb, C., Baluda, M. A., Rey, O., and Park, N.-H. (2000) In vitro replication and differentiation of normal human oral keratinocytes. Exp. Cell Res. 258, 288–297.
Kim, N. W., Piatyszek, M. A., Prowse, K. R., et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015.
Greider, C. W. and Blackburn, E. H. (1987) The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51, 887–898.
Greider, C. W. and Blackburn, E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43(2 Pt 1), 405–413.
Sanders, D. A. (2002) No false start for novel pseudotyped vectors. Curr. Opin. Biotechnol. 13, 437–442.
Akkina, R. K., Walton, R. M., Chen, M. L., Li, Q. X., Planelles, V., and Chen, I. S. (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol., 70, 2581–2585.
Gulizia, J., Dempsey, M. P., Sharova, N., Bukrinsky, M. I., Spitz, L., Goldfarb, D., and Stevenson, M. (1994) Reduced nuclear import of human immunodeficiency virus type 1 preintegration complexes in the presence of a prototypic nuclear targeting signal. J. Virol. 68, 2021–2025.
Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J. K. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033–8037.
VandenDriessche, T., Collen, D., and Chuah, M. K. (2003) Biosafety of oncoretroviral vectors. Curr. Gene Ther. 3, 501–515.
Munger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., Howley, P. M. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8, 4099–4105.
Rane, S. G., Cosenza, S. C., Mettus, R. V., Reddy, E. P. (2002) Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Mol. Cell. Biol. 22, 644–656.
Kang, M. K., Swee, J., Kim, R. H., Baluda, M. A., and Park, N.-H. (2002) The telomeric length and heterogeneity decrease with age in normal human oral keratinocytes. Mech. Ageing Dev. 123, 585–592.
Kang, M. K., Kameta, A., Shin, K.-H, Baluda, M. A., and Park, N.-H. (2004) Replicative senescence of normal human oral keratinocytes is associated with loss of telomerase activity and hTERT expression followed by limited telomere shortening. J. Cell. Physiol. 199, 264–270.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Kang, M.K., Park, NH. (2007). Extension of Cell Life Span Using Exogenous Telomerase. In: Tollefsbol, T.O. (eds) Biological Aging. Methods in Molecular Biology™, vol 371. Humana Press. https://doi.org/10.1007/978-1-59745-361-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-361-5_12
Publisher Name: Humana Press
Print ISBN: 978-1-58829-658-0
Online ISBN: 978-1-59745-361-5
eBook Packages: Springer Protocols